Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors
- 1 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 43 (6) , 835-843
Abstract
Epithelioid malignant peripheral nerve sheath tumors (EMPNST) are characterized by diffuse S-100 and SOX10 positivity, frequent immunohistochemical loss of SMARCB1 expression (70%), and rare association with neurofibromatosis type 1. Some cases arise in a preexisting epithelioid schwannoma (ESCW), which also show SMARCB1 loss in 40% of cases. To date, little is known about the genomic landscape of this distinctive variant of malignant peripheral nerve sheath tumor. The aim of this study was to use targeted next-generation sequencing to identify recurrent genomic aberrations in EMPNST and a subset of ESCW, including the basis of SMARCB1 loss. Sixteen EMPNSTs (13 SMARCB1-lost, 3 SMARCB1-retained) and 5 ESCWs with SMARCB1 loss were selected for the cohort. Sequencing identified SMARCB1 gene inactivation in 12/16 (75%) EMPNST and all 5 (100%) ESCW through homozygous deletion (N=8), nonsense (N=7), frameshift (N=2), or splice site (N=2) mutations; 2 EMPNSTs harbored 2 concurrent mutations each. SMARCB1 immunohistochemistry status and SMARCB1 alterations were concordant in 20/21 of the sequenced tumors. Additional genetic alterations in a subset of EMPNST included inactivation of CDKN2A and gain of chromosome 2q. Among SMARCB1-wild-type EMPNSTs there were single cases each with NF1 and NF2 mutations. No cases had SUZ12 or EED mutations. In summary, we identified recurrent SMARCB1 alterations in EMPNST (and all 5 SMARCB1-negative ESCWs tested), supporting loss of SMARCB1 tumor suppressor function as a key oncogenic event. SMARCB1-retained EMPNSTs lack SMARCB1 mutations and harbor different driver events.Keywords
This publication has 25 references indexed in Scilit:
- SMARCB1/INI1 Loss in Epithelioid SchwannomaAmerican Journal of Surgical Pathology, 2017
- Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary CarcinomasEuropean Urology, 2016
- Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNSTAmerican Journal of Surgical Pathology, 2016
- Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimicsLaboratory Investigation, 2016
- UV Signature MutationsPhotochemistry and Photobiology, 2014
- Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1PLOS ONE, 2014
- Genome‐wide approach to identify second gene targets for malignant rhabdoid tumors using high‐density oligonucleotide microarraysCancer Science, 2014
- Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumorsGenes, Chromosomes and Cancer, 2011
- Loss of SNF5 Expression Correlates with Poor Patient Survival in MelanomaClinical Cancer Research, 2009
- GermlineINI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumorGenes, Chromosomes and Cancer, 2000